Delivery Order SPE2DB20D3101-SPE2DB25FREH0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $26,530.13 to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical products, with an ultimate completion date of January 6, 2026. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child order under a larger contract vehicle, this delivery order represents part of the...
- The Defense Logistics Agency awarded a delivery order valued at $9,948.80 to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical products, with an ultimate completion date of September 23, 2025. This firm fixed-price, non-set-aside contract was awarded on September 22, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $1,715.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-160-12.5MG 30S pharmaceutical products, with an ultimate completion date of October 24, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency awarded a $2,231.38 delivery order to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical product on January 2, 2026, with completion targeted for January 5, 2026. This non-set-aside, firm fixed price delivery order was performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $2,165.44 to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product, with an ultimate completion date of October 27, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $19,138.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the pharmaceutical product AMLOD-VALSA-HCTZ 10-320-25 MG in a 30-count supply. The contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-set-aside competitive award. This delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a...
- The Defense Logistics Agency awarded a delivery order valued at $13,904.53 to AmerisourceBergen Drug Corp for the pharmaceutical product AMLOD-VALSA-HCTZ 10-320-25 MG 30S, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The product is a combination antihypertensive medication containing amlodipine, valsartan,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies under contract 4569914827, valued at $1,024.14 with a firm fixed price structure. The specific delivery involves AMLOD-VALSA-HCTZ 5-160-25 MG 30S, a combination antihypertensive medication, with an ultimate completion date of November 5, 2025. This non-set-aside, competitively awarded delivery order will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a Firm Fixed Price delivery order valued at $2,031.51 to Amerisourcebergen Drug Corp for AMLOD-VALSA-HCTZ 10-160-12.5MG 30S, a pharmaceutical product, with an ultimate completion date of January 8, 2026. This non-set-aside contract was awarded competitively on January 7, 2026, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,401.50 to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically AMLOD-VALSA-HCTZ 10-320-25 MG in a 30-count supply. This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FREH0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,054.44 to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product, on March 12, 2025, with completion expected by March 13, 2025. This competitively awarded, firm fixed-price contract was issued without set-aside status and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected based on its demonstrated capabilities to meet federal healthcare supply requirements. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract reflects DLA's strategic approach to pharmaceutical procurement through prime vendor relationships designed to ensure reliable supply of critical medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/12/25 |